These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
28. Treatment strategies in Parkinson's disease after a quarter century experiences with L-DOPA therapy. Fischer PA J Neural Transm Suppl; 1995; 46():381-9. PubMed ID: 8821073 [TBL] [Abstract][Full Text] [Related]
29. A simple rodent assay for the in vivo identification of agents with potential to reduce levodopa-induced dyskinesia in Parkinson's disease. Johnston TH; Lee J; Gomez-Ramirez J; Fox SH; Brotchie JM Exp Neurol; 2005 Feb; 191(2):243-50. PubMed ID: 15649479 [TBL] [Abstract][Full Text] [Related]
30. [Arguments in favor of the early treatment of Parkinson's disease with L-Dopa]. Broussolle E Rev Neurol (Paris); 1999 Jan; 155(1):27-33. PubMed ID: 10093845 [No Abstract] [Full Text] [Related]
31. Dopaminergic modulation of cognitive function-implications for L-DOPA treatment in Parkinson's disease. Cools R Neurosci Biobehav Rev; 2006; 30(1):1-23. PubMed ID: 15935475 [TBL] [Abstract][Full Text] [Related]
32. [Dopa-therapy in the treatment of early stage Parkinson's disease]. Broussolle E Rev Neurol (Paris); 2000; 156 Suppl 2 Pt 2():91-7. PubMed ID: 10916042 [No Abstract] [Full Text] [Related]
33. Clinical inquiries. What is the best initial treatment of Parkinson's disease? Schreck J; Kelsberg G; Rich J; Ward R J Fam Pract; 2003 Nov; 52(11):897-9. PubMed ID: 14599387 [No Abstract] [Full Text] [Related]
34. [Treatment of Parkinson disease in patients with surgical problems]. Sobolewski P Neurol Neurochir Pol; 2003; 37 Suppl 5():183-8. PubMed ID: 15098345 [TBL] [Abstract][Full Text] [Related]
35. [Revision of the treatment strategy in Parkinson disease]. Staal-Schreinemachers AL; Wesseling H; Lakke JP Ned Tijdschr Geneeskd; 1986 May; 130(20):914-8. PubMed ID: 3724865 [No Abstract] [Full Text] [Related]